Loratadine-d4

CAT: 0804-HY-17043S-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-17043S-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Loratadine-d4 is the deuterium labeled Loratadine. Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM. Loratadine has anti-dengue-virus (DENV) activity. Loratadine can inhibit immunologic release of inflammatory mediators.
CAS Number
[381727-27-1]
Product Name Alternative
Loratidine-d4; SCH 29851-d4
UNSPSC
12352005
Target
Histamine Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Others
Field of Research
Infection; Endocrinology; Inflammation/Immunology
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(/C(C2=NC=CC=C2CC3)=C4CC([2H])([2H])N(C([2H])([2H])C/4)C(OCC)=O)C3=C1
Molecular Formula
C22H19D4ClN2O2
Molecular Weight
386.91
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Kay GG, Harris AG. Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy. 1999 Jul;29 Suppl 3:147-50.; Menardo JL, Horak F, Danzig MR, Czarlewski W. A review of loratadine in the treatment of patients with allergic bronchial asthma. Clin Ther. 1997 Nov-Dec;19 (6) :1278-93; discussion 1523-4.; Monroe EW. Loratadine in the treatment of urticaria. Clin Ther. 1997 Mar-Apr;19 (2) :232-42.; Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs. 1994 Oct;48 (4) :617-37.; Roman IJ, Danzig MR. Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine. Clin Rev Allergy. 1993 Spring;11 (1) :89-110.; Shahen M, et al. Dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs. BMC Syst Biol. 2018 Jan 4;12 (1) :2.; Kleine-Tebbe J, et al. Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine. J Allergy Clin Immunol. 1994;93 (2) :494-500.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
H1 Receptor

Related Products

CatalogName
HY-17043-01Loratadine
HY-17043S1-01Loratadine-d5
HY-17043R-01Loratadine (Standard)
HY-17043S3Loratadine-13C6
HY-23188-01Loratadine-d5-1
HY-147085-01Loratadine n-oxide
HY-151912S-01Picolinafen-d4 (4-Fluorophenyl-d4)
HY-W654154Dexmedetomidine-d4 L-tartrate (-d4-major)
HY-151910S(±) -Fluoxetine-d4 Oxalate (trifluoromethylphen-d4-oxy)
HY-151892SGlimepiride-d4 (phenylethyl-α, α, β, β-d4) (cis/trans)

Alternative Products

CatalogName
TRC-L469577-10MGLoratadine-d4
MBS6057566-013-Hydroxy Loratadine-D4
sc-488748Loratadine-d4 N-Oxide
TRC-L469592-1MGLoratadine-d4 Epoxide N-Oxide
0162263-Methoxy Loratadine-d4 discontinued
318163Loratadine

Popular Products